Markets

Health Care Sector Update for 03/19/2015: FLML, NBIX, ESPR, CAPR

Top Health-care stocks:

JNJ: +0.2%

PFE: -0.5%

ABT: +0.2%

MRK: +1.0%

AMGN: +1.1%

Health-care shares were on course to end the day trading higher on Thursday.

In health-care stocks news, pharmaceutical company Flamel Technologies ( FLML ) saw its price target boosted to $21 from $17 by Roth Capital while the firm retained its buy rating.

Shares in the company were trading 1.5% higher at $17.11. Over the past 52 weeks, the company has traded between $9.30 and $19.50.

Meanwhile Neurocrine Biosciences ( NBIX ), another pharmaceutical company, saw its shares initiated by JPMorgan Chase with an overweight rating and $54 price target.

Shares in the company were trading 5.3% higher at $44.75. Over the past 52 weeks, the company has traded between $12.17 and $45.

And Esperion Therapeutics ( ESPR ) rose to a new record Thursday midday after saying late Wednesday it has priced its underwritten public offering of 1.8 million shares of common stock at $100 per share for gross proceeds of $175 million.

Shares in the company were trading 5.3% higher at $111.28 during pre-market trading . Over the past 52 weeks, the company has traded between $12.75 and $118.95.

Capricor Therapeutics, Inc. ( CAPR ) also saw its price target boosted to $12 from $8 by HC Wainright while the firm retained its buy rating.

Shares in the company were trading 5% lower at $9.75. Over the past 52 weeks, the company has traded between $3.05 and $11.10.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ESPR NBIX CAPR

Other Topics

Commodities

Latest Markets Videos